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Small intestinal biopsies were performed before and after the gluten challenge (at least 10 g natural gluten per day for 3 months in the majority) and, as judged by light microscopy and morphometric techniques, coeliac disease was confirmed in 25 (78%.) of the 32 patients; challenge was continued in the remaining 7 for a total period of 2 years when biopsies were repeated in 6 children and all were normal. Serum and RBC folate, serum iron, Hb level, and clinical symptoms were unpredictable variables in identifying children who developed gluten-induced enteropathies. The social and emotional effects of gluten challenge are discussed. The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.
Intolerance to dietary gluten is a permanent phenomenon in true coeliac disease (Mortimer et al., 1968; Sheldon, 1969; Young and Pringle, 1971; Hamilton and McNeill, 1972) and there is an increased risk of neoplasia in affected adult patients (Harris et al., 1967; Barry and Read, 1973) which may be reduced by treatment with a strict gluten-free diet (Harris et al., 1967; Holmes et al., 1976) . The application of strict diagnostic criteria (Meeuwisse, 1970) is thus of paramount importance to both child and family, and includes demonstration of abnormalities of the small intestinal mucosa induced by the ingestion of gluten. The timing of diagnostic biopsies during a gluten challenge is largely empirical particularly in those patients who remain asymptomatic, and the optimum duration of a gluten challenge has not been established.
We present results of a study designed to reappraise a past diagnosis of coeliac disease in a group of children who were being treated with a gluten-free diet. The effects of a gluten challenge on the intestinal mucosa and the clinical, emotional, and haematological effects of the challenge are reported. Patients and methods Thirty-two children were studied (Table 1) of whom one had a family history of coeliac disease. 11 patients had had a biopsy on at least one occasion. All biopsies were reviewed by one of us without knowledge of clinical details.
At the onset of the challenge 31 of the 32 patients had received a gluten-free diet (GFD) for at least 1 year with a mean and range of 6 v 5 and 0 v 25 to 11 years respectively. One patient, a 13-year-old girl, had received a GFD for only 3 months before the challenge. All 32 patients had shown clinical improvement on a GFD.
Design of the study (Fig. 1 ) Initially an empirical period of 2 months was chosen as the challenge period, but this was increased to 3 Fig. 1 Design of the study. GFD = gluten-free diet; GCD = gluten-containing diet.
months provided the children remained symptom free. Before administering the gluten challenge the patients were admitted and assessed as shown in Fig. 1 After the 3-month challenge period the patients were readmitted and assessed in a similar way to that during the first admission. The pre-and postchallenge biopsies were compared. 3 patients developed definite symptoms of gluten intolerance and were readmitted before the end of the 3-month period. The second admission of 6 patients was delayed for periods ranging from 16 to 56 weeks after the introduction of a gluten-containing diet for a variety of reasons (e.g. school commitments). When the children returned home after the second assessment parents were asked to complete a questionnaire in order to assess the emotional and social effects of the study on the children.
If the postchallenge biopsy was abnormal, GFD was reintroduced and the child assumed to have permanent gluten intolerance. If the postchallenge biopsy was normal the patient was followed as an outpatient and intestinal biopsy repeated 2 years later.
Surface to volume ratios (C/l h) were measured in all biopsy specimens (Risdon et al., 1975) . When counts fell within the normal range (26 3-56 0) the biopsies were regarded as 'normal'. Where counts were in the range previously found in untreated coeliacs (4 7-14 3) the biopsies were described as 'subtotal villous atrophy', and when counts fell in between the two ranges (i.e. 14-3-26 * 3) the biopsies were described as showing 'partial villous atrophy'.
Results (Table 2) Intestinal biopsies (Fig. 2) . Prechallenge biopsies were normal in all but 2 of the 32 patients studied. The two abnormal biopsies (1 showing 'subtotal' and 1 showing 'partial villous atrophy') were from children who had regular lapses from the diet. Both their postchallenge biopsies were completely flat.
The first 2 children in the study (Cases 8 and 9, ng/ml) ng/ml) The two children biopsied at 8 weeks had third biopsies after 12 or more weeks of gluten challenge which were completely flat. Of the remaining 30 patients, 12 had subtotal and 11 had partial villous atrophy on postchallenge biopsy. In 7 patients postchallenge biopsies were normal. Thus of the original 32 patients, gluten-induced mucosal abnormalities were shown in 25. There was no relationship between the amount of gluten ingested and the severity of histological changes in the postchallenge biopsy.
The 7 patients with normal biopsies after 12 weeks' gluten challenge remained on a gluten-containing diet for a further 2 years and 6 were then rebiopsied. All these biopsies were normal. The seventh child (Case 7, Table 2 ) remains symptom free and is growing normally after 4 years' gluten ingestion. Only 2 children in this group had biopsies before this study: one was doubtfully abnormal; the other, taken after 3 months on a GFD, was normal.
Haematological effects of gluten challenge. Although serum folate levels tended to fall during the gluten challenge, in only 5 of the 25 patients who were proved to have coeliac disease did they become abnormal. RBC folate levels remained normal in the 7 patients whose biopsies remained normal after gluten challenge. The effects of the gluten challenge on RBC levels in 19 of the remaining 25 patients are shown in Fig. 3 . Levels fell in 17 of the 19 patients, and were frankly abnormal in 5. In 2 patients RBC folate increased during the challenge. Both Hb and serum iron concentrations were unaffected by the challenge. Apprehension at home before the first admission was mainly due to anxiety about the biopsy, particularly in the younger children. In general, subsequent admissions did not increase apprehension. 2 of the younger children were upset on returning home after one or more admissions, whereas none of the older children was affected.
After careful explanation and with appropriate sedation when necessary, all children tolerated the biopsy procedure remarkably well. 4 of the younger children and 7 of the older group were frightened during the first biopsy; 2 of the younger group were less frightened by the second biopsy as was the case for all 5 children requiring a third biopsy. Delay in progress of the capsule was the chief source of anxiety during the biopsy procedure. 2 of the younger children had a persistent fear of the biopsies while this did not happen with the older children.
Gastrointestinal symptoms, dislike of glutencontaining foods, or anxiety about their possible effects were common in both age groups during the gluten-challenge period. Despite reassurance, both parents and children were apprehensive about the possibility of acute illness at the start of the challenge, although this never occurred. Difficulty in returning to a strict GFD was commoner in the younger children. With two exceptions the older children were disappointed with the gluten-containing foods and returned to their diet without regret. Needles, particularly finger pricks, were the chief source of remembered distress in all children. 6 children regularly ate oats (e.g. porridge) throughout the year. All had normal prechallenge biopsies and in 5 the diagnosis of coeliac disease was confirmed.
Discussion
Ideally coeliac disease is confirmed by biopsy at the time of initial diagnosis. However, this may sometimes not be practical in young sick infants. Early introduction of mixed feeding may have resulted in some coeliac children presenting at an earlieragewhen, because of their small size and often poor physical condition, biopsy may veryoccasionallybe considered unwise. It should be stressed, however, that biopsy before introducing a GFD is an important diagnostic criterion. In young sick infants this procedure should be performed in experienced centres in order to minimise complications. Also other conditions which may produce mucosal abnormalities similar to those seen in coeliac disease are commoner in children under 1 year (Anderson et al., 1972) and confirmation of the diagnosis should be undertaken later, before commitment to a life-long GFD.
Of the 31 patients who had been receiving a GFD for a mean period of 6 5 years, 24 were shown to have coeliac disease by gluten challenge. 6 of the remaining 7 had normal biopsies after ingestion of at least 10 g gluten per day for 2 years, and may be considered not to have coeliac disease. In 1 of these 7 children previous biopsy had been reported as abnormal, but we were unable to confirm the original report. This emphasises the need for experienced interpretation of biopsies before committing patients to gluten-free diets for life. Objective methods of assessing mucosal morphology may be helpful in this respect (Risdon and Keeling, 1974) .
The nature and optimal duration of a gluten challenge are controversial topics and have not been clearly defined (McNeish, 1968; Hamilton and McNeill, 1972; Rolles et al., 1975) . Rolles et al. (1975) gave 20 g per day commercial gluten powder to their patients, whereas Hamilton and McNeill (1972) used one slice of bread per day (approximately 2 5 g gluten). In most other studies in children the daily intake of gluten has not been controlled. It has been suggested that the administration of commercial gluten powder prevents the child becoming accustomed to gluten-containing foods and the possible difficulties of returning to a GFD after a positive challenge (Rolles et al., 1975) are avoided. Only 4 of 19 patients specifically questioned experienced such difficulties in our study.
The earliest mucosal changes induced by gluten in coeliac disease require electronmicroscopy or enzyme histochemistry for their definition (Bayless et al., 1970) . Our aim was to establish the time interval required after the reintroduction of dietary gluten for the development of unequivocal changes easily demonstrable by light microscopy. The results indicate that for practical purposes a normal biopsy after a 3-to 4-month gluten challenge of at least 10 g natural gluten excludes a diagnosis of coeliac disease. Where, as in this study, prechallenge 'control' biopsies are available for comparison, accurate assessment of the mucosal lesion may be aided by the application ofmorphometric techniques.
Because of the variation in time required for gluten to induce mucosal changes, a reliable symptom or screening test would be useful as an aid to timing of the second biopsy. In this study development of symptoms and signs during the challenge period was a very unreliable indication of gluten-induced mucosal abnormalities. Only 4 coeliacs developed definite clinical manifestations. Equivocal symptoms such as 'loose' stools, vague abdominal pain, and mild irritability were common during the first week or two after reintroducing gluten in children with both normal and abnormal postchallenge biopsies and in the majority of patients these resolved after reassurance.
Such symptoms are presumably related to apprehension and are not an indication for bringing forward the second biopsy. Rolles et al. (1975) found in young infants that the clinical response to a gluten challenge was much more rapid, but in our study there was no relationship between age at biopsy and severity of biopsy changes.
The 1-hour blood xylose test has been reported as a useful procedure in the timing of postchallenge biopsies (Rolles et al., 1975 ) but this has not been our experience (Lamabadusuriya et al., 1975) . In the present study both Hb and serum iron values were unaffected by gluten challenge. As judged by oral load tests, absorption of folic acid is impaired in adults with 'idiopathic sprue' (Chanarin and Bennett, 1962) and coeliac disease (Hoffbrand et al., 1970) . McNeish and Willoughby (1969) measured whole-blood folate levels, which mainly reflects red cell folate, in 30 children with untreated coeliac disease, and found it to be reduced in all patients; serum folate was also reduced in all these patients, but it was also low in 5 of 12 control subjects. In this study we measured pre-and postchallenge serum and RBC folate concentrations. Of the patients who were shown to have coeliac disease, serum and RBC folate fell to abnormal levels in 7 and 8 patients respectively, suggesting that the symptoms and screening tests of a gluten challenge are unreliable in predicting which patients will develop gluteninduced enteropathy. Our patients had received a GFD for a mean period of 6 * 5 years, and the mean age at the onset of gluten challenge was 9 9 years. In children of this age who have received dietary treatment for several years we would recommend a 3-to 4-month period of gluten ingestion; the finding of a normal postchallenge biopsy excludes coeliac disease. We suggest, however, that they be followed up for a further 2 years and, in accordance with the international study (Meeuwisse, 1970) , rebiopsed at this time.
The social and emotional impact of a gluten challenge was assessed by means of a questionnaire sent to the parents after the child's second admission.
Apprehension at home before admission was due mainly to anxiety of the biopsy procedure itself, particularly in younger children. All children tolerated the biopsy procedure well. 2 of the younger children had a persistent fear of biopsies, while this was not the case in any of the older children. Needles, not the biopsy procedure, were the chief source of remembered distress in all children. In the majority of the older children no problems were encountered on returning to a GFD whereas difficulties were common in the younger age group. Careful explanation of the biopsy procedure to the child and parents by the person who actually performed the biopsy was important in preparing the whole family for the child's admission, This was particularly the case in the younger children who were much more dependent on their parents for reassurance and explanation at all stages. The older children were able to understand the reason for the biopsies and challenge, and this was reflected in an extraordinary degree of co-operation in all aspects of the study.
The optimal age for gluten challenge is controversial. Early challenge would resolve dietary difficulties encountered with school lunches and parties and for some children would eliminate many years of unnecessary treatment. The major objection is the emotional stress to the young child compared with the older one, and the resulting demands on the family. Challenge in older children has the advantage of considerably greater understanding and co-operation from the child, and less stress for the rest of the family. The planning of a challenge at any age should take into consideration the known emotional requirements of children at different ages, and should also recognise the anxiety and stress which may be felt by the whole family. The performance of biopsies on a day-care basis may reduce these anxieties and stresses, but requires evaluation.
The exclusion of oats and barley from the diet of a child with coeliac disease remains controversial (Anderson et al., 1972) . Dissanayake et al. (1974) administered 40-60 g porridge oats for 1 month to adults with coeliac disease. The patients remained symptom free, and jejunal biopsies were normal after the challenge; the authors concluded that oats are harmless to coeliac subjects and can be included in a GFD. Mucosal damage may be delayed (Case 9) but in the present study 5 children, who were proved to have coeliac disease and who had normal prechallenge biopsies, had regularly eaten oats for at least a year before the challenge. These findings tend to support the observations of Dissanayake et al. 
